Author Information
Michael Abrahamowicz is a prominent researcher affiliated with the Department of Epidemiology, Biostatistics and Occupational Health at McGill University, Canada. He is also associated with The Research Institute of the McGill University Health Centre, Canada. His research primarily focuses on epidemiology and biostatistics, contributing significantly to public health sciences.Research Contributions
Michael Abrahamowicz has made substantial contributions to the field of epidemiology, with a notable emphasis on methodological advancements in biostatistics. In 2021, his research spanned various critical areas, including the agreement between self-reported medication use and claim data, trends in the risk of acute myocardial infarction in rheumatoid arthritis patients, long-term exposure to wildfires and cancer incidence, and the effects of intravenous radiocontrast on kidney function. Additionally, he explored the associations between opioid consumption profiles and adverse health events, the ACE2 gene's role in COVID-19 severity, and the validation of a lupus multivariable outcome score. His work also addressed methodological issues in heart failure prediction models and assessed the relative effectiveness of influenza vaccines in elderly persons.Aliases
Michael Abrahamowicz is also known by several aliases, including Michał Abrahamowicz, M. Abrahamowicz, and Michal Abrahamowicz. These variations of his name are commonly used in academic publications and citations.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
24,976 |
| h-index |
81 |
| Total Paper Count |
474 |
